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SUMMARY Clear cell hidradenoma is a rare skin append-
age tumor. A 41-year-old female presented with right gluteal 
mass. Excisional biopsy of the mass was performed. Under 
the epidermis, an eosinophilic-cytoplasm, uniform-appear-
ance, oval-round-nucleus, benign tumor with cystic and solid 
components was detected. These results were consistent 
with clear cell hidradenoma. The patient had not been given 
postoperative adjuvant treatment and has been under follow 
up free from disease for 2 years. 
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IntRodUCtIon
 Clear cell hidradenoma is among the skin ap-
pendage tumors and gluteal localization is rare 
(1). Generally, it grows slowly and appears as a 
solitary dermal nodule under the skin for many 
years. It is mostly a benign, occasionally capsular 
(2,3), well-limited neoplasm containing solid and 
cystic components together. 
CASe RePoRt
 A 41-year-old female presented to our clinic 
with the complaint of gradually increasing swell-
ing that had been present in her right hip for 3 
years. Her physical examination revealed a 4x4-
cm mass in her right gluteal region. No regional 
lymphadenopathy was detected and other system 
examinations were normal. Excisional biopsy of 
the mass was performed with 1 cm clear margin. 
Macroscopically, tissue sample was of a cystic 
nature. Pathological examination revealed a well-
limited, eosinophilic-cytoplasm, benign neoplasm 
with a thin fibrous capsule under the epidermis 
that constituted solid cell layers within the cystic 
space and was composed of oval-round-nucleus 
cells (Fig. 1). Immunochemistry showed positive 
staining with cytokeratin (Fig. 2), PAS (Fig. 3) and 
p63 (Fig. 4). Based on these results, the diagnosis 
of clear cell hidradenoma was made. Wide surgi-
cal excision was not required because the tumor 
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was excised with a wide and safe margin on all 
sides. Adjuvant therapy was not administered. The 
patient has been under follow up at six-month in-
tervals, free from recurrence on tomography taken 
at the last control visit. Considering the localiza-
tion site, only one case has been reported in the 
literature besides this one. 
copy images showing microvillus processes, and 
enzyme histochemistry (7). Many different terms 
are used for clear cell hidradenoma, i.e. clear cell 
myoepithelioma, nodular hidradenoma, eccrine 
sweat gland adenoma of clear cell type, solid cys-
tic hidradenoma, and eccrine acrospiroma (7,8). 
However, more emphasis is put on the opinion 
that it is mainly of apocrine origin (9,10). In gen-
eral, there are solitary lesions with a 1- to 2-cm 
diameter. However, there also are larger in size 
and multiple cases reported in the literature. Com-
dISCUSSIon 
 Although it can occur nearly at any age, clear 
cell hidradenoma is mostly frequently diagnosed 
from the fourth to eighth decade of life (4). It is 
more common in women than in men (5). The first 
case in the literature was described by Delacre-
taz et al. in 1958 (6). There are different opinions 
on its origin. Some authors suggest that it is of 
eccrine origin, based on the number of mitochon-
dria, excess glycogen granules, electron micros-
Figure 4. Positive nuclear staining with p63 
(X100).
Figure 1. Benign tumor under the epidermis with 
a thin fibrous capsule, eosinophilic cytoplasm and 
oval-round nucleus (hematoxylin and eosin; X20).
Figure 2. Positive cytoplasmic staining with cyto-
keratin (X40).
monly, they tend to be located in the upper part of 
the body such as the head, face, upper extremity 
and abdomen (5,11,12).  
 Pathologically, clear cell hidradenoma consists 
of two cell types. The first includes epidermal poly-
hedral-structure cells with generally round nuclei 
and mildly basophilic cytoplasm. The second in-
cludes round and transparent-cytoplasm clear 
cells (8,11). Cystic areas probably result from de-
generation of tumor cells.
Figure 3. Positive cytoplasmic staining with PAS 
(X100).
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 Malignant form is rare. It is characterized by 
nuclear atypia, mitosis, necrosis and invasion to 
the surrounding tissue (5,11). Malignant transfor-
mation may occur after inadequate surgical exci-
sion. Metastasis sites commonly include lymph 
nodes, bones and lungs (2,13). 
 Fine-needle aspiration biopsy is not enough to 
make the diagnosis. Excisional biopsy is required 
for both diagnosis and treatment. Immunohisto-
chemistry staining is a supplementary technique 
in diagnosis. While clear cell hidradenoma exhib-
its a positive staining with cytokeratin, PAS and 
p63, it shows negative staining with S100, CD10, 
CD34 and vimentin (2,3,11,14). Our patient had 
the same immunohistochemistry staining results. 
 Although optimal treatment has not yet been 
definitely identified, the currently accepted ap-
proach is extensive surgical excision with nega-
tive surgical margins (4,11). There is no adjuvant 
treatment recommended postoperatively. Adjuvant 
treatment options including chemotherapy and/or 
radiotherapy have only been proposed for malig-
nant clear cell hidradenoma. Therefore, we did not 
use any adjuvant treatment in our patient. We put 
our patient under follow up after extensive surgical 
excision with wide and safe margin to leave intact 
tissue space. Until now, no recurrence was de-
tected on physical examination and tomographic 
images taken at six-month intervals.
 Local recurrence rate is high and may be ob-
served following inadequate surgical resection 
(2,11). In recurrent cases, surgical re-excision is 
usually performed (13).
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